Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Omeros Corp
(NQ:
OMER
)
4.080
+0.010 (+0.25%)
Streaming Delayed Price
Updated: 10:52 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Omeros Corp
< Previous
1
2
3
4
5
6
7
8
Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
September 27, 2021
Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:
Via
Benzinga
Looking Into Omeros's Return On Capital Employed
September 20, 2021
According to data from Benzinga Pro, during Q2, Omeros's (NASDAQ:OMER) reported sales totaled $28.82 million. Despite a 21.55% increase in earnings, the company posted a loss of $...
Via
Benzinga
Omeros: Q2 Earnings Insights
August 09, 2021
Shares of Omeros (NASDAQ:OMER) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 24.59% year over year to...
Via
Benzinga
Earnings Scheduled For May 10, 2021
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Omeros Corporation Reports Second Quarter 2021 Financial Results
August 09, 2021
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce Second Quarter Financial Results on August 9, 2021
August 03, 2021
From
Omeros Corporation
Via
Business Wire
Return On Capital Employed Overview: Omeros
June 24, 2021
Omeros (NASDAQ:OMER) reported Q1 sales of $21.06 million. Earnings fell to a loss of $30.61 million, resulting in a 9.47% decrease from last quarter. In Q4, Omeros brought in $10....
Via
Benzinga
Omeros' Narsoplimab Associated With Improvement In Organ Function In Stem Cell Transplant Patients
June 14, 2021
Omeros Corporation (NASDAQ: OMER) has announced the presentation of data on organ function improvement from its pivotal trial of narsoplimab for the treatment of...
Via
Benzinga
Earnings Scheduled For August 9, 2021
August 09, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...
Via
Benzinga
Omeros’ Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 2021 Annual Congress of the European Hematology Association
June 14, 2021
From
Omeros Corporation
Via
Business Wire
Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction
June 10, 2021
From
Omeros Corporation
Via
Business Wire
Omeros to Present at the BofA 2021 Napa BioPharma Virtual Conference
June 09, 2021
From
Omeros Corporation
Via
Business Wire
Omeros Announces Preliminary Results from Phase 1 Clinical Trial of OMS906
June 09, 2021
From
Omeros Corporation
Via
Business Wire
Omeros: Return On Capital Employed Insights
June 08, 2021
Omeros (NASDAQ:OMER) reported Q1 sales of $21.06 million. Earnings fell to a loss of $30.61 million, resulting in a 9.47% decrease from last quarter. Omeros collected $10.63...
Via
Benzinga
Omeros's Narsoplimab Shows Encouraging Action In Critically Ill COVID-19 Patients
May 28, 2021
Omeros Corporation (NASDAQ: OMER) has announced preliminary results from the second cohort (n=10) of critically ill COVID-19 patients treated with narsoplimab in...
Via
Benzinga
Exposures
COVID-19
Omeros Announces Preliminary Results from Additional Critically Ill COVID-19 Patients Treated with Narsoplimab
May 28, 2021
From
Omeros Corporation
Via
Business Wire
60 Biggest Movers From Yesterday
May 21, 2021
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 20, 2021
Gainers PDS Biotechnology (NASDAQ:PDSB) shares increased by 18.99% to $6.83 during Thursday's regular session. PDS Biotechnology's stock is trading at a volume of...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
May 20, 2021
Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03. Precipio, Inc. (NASDAQ: PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-...
Via
Benzinga
Omeros's Narsoplimab US Application Review Pushed By 3 Months, Shares Drop
May 20, 2021
Omeros Corporation (NASDAQ: OMER) has revealed that the FDA needs additional time to review narsoplimab marketing application for hematopoietic stem cell...
Via
Benzinga
Exposures
Product Safety
Omeros Announces Extension of FDA Review Period for Narsoplimab in HSCT-TMA
May 20, 2021
From
Omeros Corporation
Via
Business Wire
Omeros’ Narsoplimab Pivotal Trial Data to Be Shared as an Oral Presentation at the European Hematology Association Congress
May 13, 2021
From
Omeros Corporation
Via
Business Wire
Omeros: Q1 Earnings Insights
May 10, 2021
Shares of Omeros (NASDAQ:OMER) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 7.55% over the past year to...
Via
Benzinga
Omeros Corporation Reports First Quarter 2021 Financial Results
May 10, 2021
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 10, 2021
May 05, 2021
From
Omeros Corporation
Via
Business Wire
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
Omeros Corporation Announces Approval of ICD-10 Codes for HSCT-TMA Diagnosis and for Narsoplimab Administration
May 04, 2021
From
Omeros Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.